Trexquant Investment LP Buys New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Trexquant Investment LP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 76,380 shares of the company's stock, valued at approximately $22,925,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the 3rd quarter worth $39,000. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC purchased a new position in HCA Healthcare in the fourth quarter worth approximately $36,000. Activest Wealth Management increased its position in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on HCA. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. Morgan Stanley lowered their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 17th. Finally, Barclays lowered their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

Remove Ads

HCA Healthcare Price Performance

Shares of HCA traded up $1.75 on Wednesday, reaching $347.48. The stock had a trading volume of 1,249,318 shares, compared to its average volume of 1,349,682. The firm has a 50-day moving average of $326.35 and a 200 day moving average of $340.30. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $85.55 billion, a PE ratio of 15.82, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a dividend of $0.72 per share. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's dividend payout ratio (DPR) is presently 13.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.